A case of cutaneous variant of intravascular large B-cell lymphoma in which dermoscopy revealed telangiectasias associated with erythematous induration
HTML: 7
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Intravascular large B-cell lymphoma (IVLBCL) is a rare type of extranodal, diffuse, large B-cell lymphoma characterized by the selective growth of lymphoma cells within the lumen of small blood vessels, with no lymphadenopathy or masses. Herein, we report a cutaneous variant of IVLBCL that is rare in Asia. A healthy 73-year-old Japanese woman presented to our hospital with painful erythematous indurations and telangiectasia of the lower extremities, which was confirmed on dermoscopy. Physical examination revealed no systemic involvement, and laboratory parameters were within normal ranges. No abnormal fluorodeoxyglucose (FDG) uptake was detected on 18FDG positron emission tomography/computed tomography. Histopathological examination revealed proliferation and dilatation of blood vessels in the subcutis layer, occluded by CD20-positive atypical lymphoid cells. Thus, the patient was diagnosed with a cutaneous variant of IVLBCL without systemic symptoms. In conclusion, it is important to confirm telangiectasia using dermoscopy and perform skin biopsies in patients presenting with sudden-onset erythematous induration.
Ponzoni M, Campo E, Nakamura S. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. Blood 2018;132:1561-7. DOI: https://doi.org/10.1182/blood-2017-04-737445
Ponzoni M, Ferreri AJ, Campo E, et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 2007;25:3168-73. DOI: https://doi.org/10.1200/JCO.2006.08.2313
Han Y, Li Q, Wang D, et al. Case report: intravascular large B-cell lymphoma: a clinicopathologic study of four cases with review of additional 331 cases in the literature. Front Oncol 2022;12:883141. DOI: https://doi.org/10.3389/fonc.2022.883141
Ferreri AJ, Campo E, Seymour JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 2004;127:173-83. DOI: https://doi.org/10.1111/j.1365-2141.2004.05177.x
Park JH, Lee DY, Ko YH. Intravascular large B-cell lymphoma of the cutaneous variant in Korea. J Dermatol 2011;38:160-3. DOI: https://doi.org/10.1111/j.1346-8138.2010.01100.x
Saito T, Matsuya T, Takahashi C, et al. Cutaneous variant of intravascular large B‐cell lymphoma in a Japanese patient: an occult lesion localized in a solitary angiolipoma. J Dermatol 2017;44:e28-9. DOI: https://doi.org/10.1111/1346-8138.13504
Takeuchi M, Sato Y, Taguchi R, et al. Intravascular large B-cell lymphoma presenting with annular erythema. rinsho derma (Japanese) 2020;62:587-90.
Arai T, Kato Y, Funaki M, et al. Three cases of intravascular large B-cell lymphoma detected in a biopsy of skin lesions. Dermatology 2016;232:185-8. DOI: https://doi.org/10.1159/000437363
Miyano K, Matsura K, Murakami T, et al. Intravascular large B-cell lymphoma associated with Telangiectasia on the trunk and lower limbs. rinsho derma (Japanese) 2019;61:1557-61.
Röglin J, Böer A. Skin manifestations of intravascular lymphoma mimic inflammatory diseases of the skin. Br J Dermatol 2007;157:16-25. DOI: https://doi.org/10.1111/j.1365-2133.2007.07954.x
Martin IG, Ankad BS, Errichetti E, Lallas A, Ioannides D, Zaballos P. Leprosy. In: Lallas A, Errichetti E, Ioannides D, eds. Dermoscopy in general dermatology. Boca Raton, FL: CRC Press; 2019. pp 191-5.
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.